Emerald Acquisition’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
AIC
CWAM
DCM
BIT
BFA
Emerald Acquisition's LMAT Position: Q3 2016 in Review
Emerald Acquisition reduced its LeMaitre Vascular (LMAT) stake by 56% in Q3 2016, selling an estimated $880K and leaving 39,561 shares worth $785K. The position accounts for ﹤0.01% of the portfolio, ranked #2250.
Emerald Acquisition first reported a position in LMAT in Q2 2016 and has held it in 2 quarters since. The position peaked at $1.28M in Q2 2016. 111 funds tracked by Wall St. Rank hold LMAT as of Q3 2016.
- Emerald Acquisition held 39,561 shares of LeMaitre Vascular worth $785K as of Q3 2016.
- Emerald Acquisition sold 50,360 LeMaitre Vascular shares in Q3 2016, an estimated $880K.
- LeMaitre Vascular made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2250 holding.
- Emerald Acquisition first reported a position in LeMaitre Vascular in Q2 2016 and has held it in 2 quarters since.
- Emerald Acquisition's LeMaitre Vascular position peaked at $1.28M in Q2 2016.
- 111 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2016.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.